Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Aline Meireles Coelho, Isabela Ferreira Queiroz, Wanderson Geraldo Lima, André Talvani, Luiza Oliveira Perucci, Melina Oliveira de Souza & Daniela Caldeira Costa. (2023) Temporal analysis of paracetamol-induced hepatotoxicity. Drug and Chemical Toxicology 46:3, pages 472-481.
Read now
Read now
Sangeetha Nithiyanandam & Sabina Evan Prince. (2021) Toxins mechanism in instigating hepatotoxicity. Toxin Reviews 40:4, pages 616-631.
Read now
Read now
Giuseppe Miscio, Giulia Paroni, Paola Bisceglia, Carolina Gravina, Maria Urbano, Madia Lozupone, Carla Piccininni, Michele Prisciandaro, Grazia Ciavarella, Antonio Daniele, Antonello Bellomo, Francesco Panza, Lazzaro Di Mauro, Antonio Greco & Davide Seripa. (2019) Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline. Expert Opinion on Drug Metabolism & Toxicology 15:9, pages 751-765.
Read now
Read now
Chunyong He & Hong Wan. (2018) Drug metabolism and metabolite safety assessment in drug discovery and development. Expert Opinion on Drug Metabolism & Toxicology 14:10, pages 1071-1085.
Read now
Read now
Sun-Jae Lee, Youn Ju Lee & Kwan-Kyu Park. (2016) The pathogenesis of drug-induced liver injury. Expert Review of Gastroenterology & Hepatology 10:10, pages 1175-1185.
Read now
Read now
Articles from other publishers (36)
Mannala Sunil, T Vedavijaya, Rohit Singh Thakur, Karuna Sree P, Venkata Ramana Yella & Suresh Babu Sayana. (2023) Evaluation of the Ethanolic Leaf Extract of Abutilon indicum on Isonicotinic Acid Hydrazide-Induced Proinflammatory Marker Gene Expression Changes. Cureus.
Crossref
Crossref
Xinyu Li, Chengxian Li, Chenyi Li, Chengzhao Wu, Yuxuan Bai, Xu Zhao, Zhaofang Bai, Xigang Zhang, Xiaohe Xiao & Ming Niu. (2023) A novel perspective on the preventive treatment of hydrazine compound-induced liver injury: Isoniazid liver injury as an example. Journal of Ethnopharmacology 315, pages 116616.
Crossref
Crossref
Arnold Kukowka, Bogusław Brzuchalski, Mateusz Kurzawski, Damian Malinowski & Monika Anna Białecka. (2023) ADH1B, ADH1B/C and CYP2E1 Gene Polymorphism and the Risk of Fetal Alcohol Spectrum Disorder. Genes 14:7, pages 1392.
Crossref
Crossref
Kessada Tunwongsa, Malinee Chonnawakul, Nopavut Geratikornsupuk & Karunrat Tewthanom. (2022) Genetic screening to avoid adverse drug reactions from medication use and approach patients' better outcomes: A lesson learn from the report of the Queen Savang Vadhana Memorial Hospital. Health Science Reports 5:3.
Crossref
Crossref
Veronique Michaud, Lucy I. Darakjian, Pamela Dow & Jacques Turgeon. (2022) Role of Pharmacogenomics in Reducing the Risk of Drug-Related Iatrogenesis. Current Pharmacology Reports 8:2, pages 79-98.
Crossref
Crossref
Abebe Dukessa Dubiwak, Urge Gerema, Daba Abdisa, Ebsa Tofik & Wondu Reta. (2022) Amelioration of Nephrotoxicity in Mice Induced by Antituberculosis Drugs Using Ensete ventricosum (Welw.) Cheesman Corm Extract. International Journal of Nephrology 2022, pages 1-8.
Crossref
Crossref
Vandana Saini, Anju Goyal & Ajay Kumar. (2022) Isoniazid: An Exploratory Review. Asian Journal of Organic & Medicinal Chemistry 7:1, pages 1-10.
Crossref
Crossref
Melisa Intan Barliana, Arif Satria Wira Kusuma, Widya Norma Insani, Sofa Dewi Alfian, Ajeng Diantini, Mutakin Mutakin, Tina Rostinawati, Herlambang Herlambang, Irma Melyani Puspitasari, Auliya Abdurrohim Suwantika & Rizky Abdulah. (2021) Genetic variation of ABCB1 (rs1128503, rs1045642) and CYP2E1 rs3813867 with the duration of tuberculosis therapy: a pilot study among tuberculosis patients in Indonesia. BMC Research Notes 14:1.
Crossref
Crossref
Neil W. Schluger. (2021) Using Isoniazid More Safely and More Effectively: The Time Is Now. American Journal of Respiratory and Critical Care Medicine 204:11, pages 1248-1250.
Crossref
Crossref
Xinmei Li, Heng Zhang, Lin Xu, Yuan Jin, Jiao Luo, Chuanhai Li, Kunming Zhao, Yuxin Zheng, Dianke Yu & Yanjie Zhao. (2021) miR-15a-3p Protects Against Isoniazid-Induced Liver Injury via Suppressing N-Acetyltransferase 2 Expression. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
G. I. Kotsyumbas & N. P. Vretsona. (2021) Histological and histochemical changes in the peripheral organs of the immune system of dogs in cases of isoniazid poisoning. Regulatory Mechanisms in Biosystems 12:3, pages 537-544.
Crossref
Crossref
Vasyl Prysyazhnyuk, Larysa Sydorchuk, Ruslan Sydorchuk, Iryna Prysiazhniuk, Kateryna Bobkovych, Inna Buzdugan, Valentina Dzuryak & Petro Prysyazhnyuk. (2021) Glutathione-S-transferases genes-promising predictors of hepatic dysfunction. World Journal of Hepatology 13:6, pages 620-633.
Crossref
Crossref
Saifei Lei, Ruizhi Gu & Xiaochao Ma. (2021) Clinical perspectives of isoniazid-induced liver injury. Liver Research 5:2, pages 45-52.
Crossref
Crossref
Yang FuTangyuheng LiuJiajia SongLin JiaoJuan ZhouHao BaiZhenzhen ZhaoHao ChenTao WuMengyuan LyvYi ZhouBinwu YingYanming Xu. (2021) Genetic Polymorphisms of Delta-Like 1 Homolog Influence the Susceptibility to Antituberculosis Drug-Induced Hepatotoxicity. DNA and Cell Biology 40:2, pages 231-238.
Crossref
Crossref
Zhimin Wang, Xiangzhao Ai, Zhijun Zhang, Yong Wang, Xiangyang Wu, Richard Haindl, Edwin K. L. Yeow, Wolfgang Drexler, Mingyuan Gao & Bengang Xing. (2020) NIR nanoprobe-facilitated cross-referencing manifestation of local disease biology for dynamic therapeutic response assessment. Chemical Science 11:3, pages 803-811.
Crossref
Crossref
Preena John & Pravin P. Kale. (2020) Prominence of Oxidative Stress in the Management of Anti-tuberculosis Drugs Related Hepatotoxicity. Drug Metabolism Letters 13:2, pages 95-101.
Crossref
Crossref
Amitava Dasgupta & Matthew D. Krasowski. 2020. Therapeutic Drug Monitoring Data. Therapeutic Drug Monitoring Data
159
197
.
Ya-Yen Yu, Shih-Ming Tsao, Wen-Ta Yang, Wei-Chang Huang, Ching-Hsiung Lin, Wei-Wen Chen, Shun-Fa Yang, Hui-Ling Chiou & Yi-Wen Huang. (2019) Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis. International Journal of Environmental Research and Public Health 17:1, pages 210.
Crossref
Crossref
Xiao-hua Wang, Yong-wen Jin, Zhi Rao, Guo-qiang Zhang, Kai-hong Zang & Hong-yan Qin. (2019) Curcumin Enhances the Systemic Exposure of Isoniazid in Rats: Role of NAT2 in the Liver and Intestine. International Journal of Pharmacology 16:1, pages 10-17.
Crossref
Crossref
Ying Zhu, Qiong Shi, Qi Peng, Yue Gao, Ting Yang, Yu Cheng, Hao Wang, Yetao Luo, Ailong Huang, Tong‑Chuan He & Jiaming Fan. (2019) A simplified 3D liver microsphere tissue culture model for hepatic cell signaling and drug-induced hepatotoxicity studies. International Journal of Molecular Medicine.
Crossref
Crossref
Jiajia Song, Tangyuheng Liu, Zhenzhen Zhao, Xuejiao Hu, Qian Wu, Wu Peng, Xuerong Chen & Binwu Ying. (2019)
Genetic polymorphisms of long noncoding RNA
RP11‐37B2.1
associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China
. Journal of Clinical Laboratory Analysis 33:5.
Crossref
Crossref
Emily R. Erwin, Angela P. Addison, Sarah Finney John, Omonike Arike Olaleye & Rosemarie C. Rosell. (2019) Pharmacokinetics of isoniazid: The good, the bad, and the alternatives. Tuberculosis 116, pages S66-S70.
Crossref
Crossref
Passisd Laoveeravat, Nicha Wongjarupong, Chonlada Phathong, Cameron Hurst, Sombat Treeprasertsuk, Rungsun Rerknimitr & Roongruedee Chaiteerakij. (2019) Characteristics and risk factors for antituberculosis drug-induced liver injury in a cohort of patients with cirrhosis in a tertiary referral university teaching hospital in Thailand. Asian Biomedicine 12:2, pages 65-74.
Crossref
Crossref
Sinisa Djurasevic, Zoran Todorovic, Sladjan Pavlovic & Snezana Pejic. 2019. Dietary Interventions in Liver Disease. Dietary Interventions in Liver Disease
333
344
.
Alice K. Pau, Safia Kuriakose, Kelly E. Dooley & Gary Maartens. 2019. HIV and Tuberculosis. HIV and Tuberculosis
181
202
.
Min Zhang, Shuqiang Wang, Bob Wilffert, Rongsheng Tong, Dick van Soolingen, Susan van den Hof & Jan-Willem Alffenaar. (2018)
The association between the
NAT2
genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
. British Journal of Clinical Pharmacology 84:12, pages 2747-2760.
Crossref
Crossref
Xiaoyu Qu, Yueming Zhang, Sixi Zhang, Jinghui Zhai, Huan Gao, Lina Tao & Yanqing Song. (2018) Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury <i>via</i> the SIRT1/FXR Pathway in Rats and HepG2 Cells. Biological and Pharmaceutical Bulletin 41:8, pages 1211-1218.
Crossref
Crossref
Wing Wai Yew, Kwok Chiu Chang & Denise P. Chan. (2018) Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity. Antimicrobial Agents and Chemotherapy 62:8.
Crossref
Crossref
David M. Burger, Lindsey H. M. te Brake & Rob E. Aarnoutse. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
15
47
.
Jing Li, Lijuan Wu, Weihua Guo, Juli Chen, Xuejiao Hu, Minjin Wang, Zhenzhen Zhao & Binwu Ying. (2017)
Clinical relevance of
LINC00152
and its variants in western Chinese tuberculosis patients
. Oncotarget 8:70, pages 115456-115468.
Crossref
Crossref
Hozeifa M. Hassan, Hongli Guo, Bashir A. Yousef, Ding Ping-Ping, Luyong Zhang & Zhenzhou Jiang. (2017) Dexamethasone Pretreatment Alleviates Isoniazid/Lipopolysaccharide Hepatotoxicity: Inhibition of Inflammatory and Oxidative Stress. Frontiers in Pharmacology 8.
Crossref
Crossref
Rihwa Choi, Byeong-Ho Jeong, Won-Jung Koh & Soo-Youn Lee. (2017) Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations. Annals of Laboratory Medicine 37:2, pages 97-107.
Crossref
Crossref
Christoph Thiel, Henrik Cordes, Isabel Conde, José Vicente Castell, Lars Mathias Blank & Lars Kuepfer. (2016) Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients. Archives of Toxicology 91:2, pages 865-883.
Crossref
Crossref
Sodam JungSang-Hoon KimJang Won SohnHo Joo YoonDong Ho ShinYoung-Koo JeeSang-Heon Kim. (2017) Genetic polymorphisms of interleukin-10 and transforming growth factor-?1 and antituberculosis drugs-induced liver injury. Allergy, Asthma & Respiratory Disease 5:1, pages 41.
Crossref
Crossref
Hozeifa Mohamed Hassan, Hongli Guo, Bashir Alsiddig Yousef, Mounia Guerram, Aida Mejda Hamdi, Luyong Zhang & Zhenzhou Jiang. (2016) Role of Inflammatory and Oxidative Stress, Cytochrome P450 2E1, and Bile Acid Disturbance in Rat Liver Injury Induced by Isoniazid and Lipopolysaccharide Cotreatment. Antimicrobial Agents and Chemotherapy 60:9, pages 5285-5293.
Crossref
Crossref
Dyah A. Perwitasari, Lalu M. Irham, Endang Darmawan, Ully A. Mulyani & J. Atthobari. (2016) CYP2E1 polymorphism, acetylator profiles and drug-induced liver injury incidence of Indonesian tuberculosis patients. Indian Journal of Tuberculosis 63:3, pages 139-143.
Crossref
Crossref